Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq
Clinical trial NCT06780332 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06780332
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-07
- Primary completion
- 2026-08-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.